These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9828829)

  • 1. Antibody panel in diagnosis of lymphoid neoplasms.
    Vassallo J; Pinto GA
    J Clin Pathol; 1998 Aug; 51(8):638-9. PubMed ID: 9828829
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies specific for HeLa glycoprotein antigens are also specific for human endocervical epithelium.
    Mujica van Herckenrode C; Coleman DJ; Stanley M; Koch GL
    Br J Cancer; 1988 Mar; 57(3):293-4. PubMed ID: 3355768
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry.
    Clatch RJ; Walloch JL
    Acta Cytol; 1997; 41(1):109-22. PubMed ID: 9022735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell surface marker (CD-phenotype)].
    Takeshita A
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():293-8. PubMed ID: 17476749
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of immunocytochemical approaches to the differential diagnosis of tumors. Diagnostic applications in the clinical laboratory.
    Frisman DM
    Methods Mol Biol; 1994; 34():405-27. PubMed ID: 7711869
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel real-time PCR assay using a universal molecular marker for diagnosis of hematologic cancers.
    Shivapurkar N; Stastny V; Takahashi T; Suzuki M; Echebiri C; Reddy J; Gazdar AF
    Int J Cancer; 2005 Sep; 116(4):656-60. PubMed ID: 15825171
    [No Abstract]   [Full Text] [Related]  

  • 7. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
    Goldenberg DM
    Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal residual disease in hematological malignancies.
    Raanani P; Hochhaus A
    Acta Haematol; 2004; 112(1-2):5-7. PubMed ID: 15178998
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.
    Van Laere SJ; Elst H; Peeters D; Benoy I; Vermeulen PB; Dirix LY
    J Natl Cancer Inst; 2009 Jun; 101(12):895-6; author reply 896-7. PubMed ID: 19509352
    [No Abstract]   [Full Text] [Related]  

  • 10. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
    Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
    Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
    Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
    Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glycolipid markers in tumor cells used in immunologic and immunohistologic diagnosis of tumors. I. Factors affecting the occurrence of glycolipid tumor antigens (review)].
    Smíd F
    Cesk Patol; 1991 Jun; 27(3-4):116-23. PubMed ID: 1913919
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.
    Gillett CE; Barnes DM; Camplejohn RS
    J Clin Pathol; 1993 Dec; 46(12):1126-8. PubMed ID: 7904274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry in tumour diagnosis.
    Miettinen M
    Ann Med; 1993 Jun; 25(3):221-33. PubMed ID: 8333922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody (HML-1) labelling of T-cell lymphomas.
    Lancet; 1989 Jan; 1(8631):223-4. PubMed ID: 2563134
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology.
    Johansson U; Bloxham D; Couzens S; Jesson J; Morilla R; Erber W; Macey M;
    Br J Haematol; 2014 May; 165(4):455-88. PubMed ID: 24620735
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of central nervous system tumors.
    Birkmayer GD
    Immunol Ser; 1990; 53():317-22. PubMed ID: 2100565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical markers of neoplasms of the female genital organs. I. Tissue polypeptide antigen (TPA)].
    Kamiński K
    Ginekol Pol; 1988 Dec; 59(12):739-43. PubMed ID: 3076162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Flow cytometric analysis of cell surface antigens].
    Yoneyama A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():843-6. PubMed ID: 20942202
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
    Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.